Precision medicine‐based therapies in advanced colorectal cancer: The University of California San Diego Molecular Tumor Board experience

Treatment for advanced colorectal cancer is often limited by complex molecular profiles, which promote resistance to systemic agents and targeted monotherapies. Recent studies suggest that a personalized, combinatorial approach of matching drugs to tumor alterations may be more effective. We impleme...

Descripción completa

Detalles Bibliográficos
Autores principales: Louie, Bryan H., Kato, Shumei, Kim, Ki Hwan, Lim, Hyo Jeong, Lee, Suzanna, Okamura, Ryosuke, Fanta, Paul T., Kurzrock, Razelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251876/
https://www.ncbi.nlm.nih.gov/pubmed/35238467
http://dx.doi.org/10.1002/1878-0261.13202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251876/
https://www.ncbi.nlm.nih.gov/pubmed/35238467
http://dx.doi.org/10.1002/1878-0261.13202

Ejemplares similares